HXL Stock Analysis: Hexcel | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 6.086m USD | 12M Return: 17.2% | US4282911084 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 118M
EPS Trend: 58.6%
Qual. Beats: 0
Rev. Trend: 90.5%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Hexcel Corporation (NYSE: HXL) is a U.S.-based manufacturer of advanced lightweight composite materials, operating through two segments: Composite Materials and Engineered Products. The Composite Materials segment produces carbon fibers, fabrics, prepregs, structural adhesives, honeycomb core, molding compounds, tooling materials, polyurethane systems, and laminates for military aircraft, transportation, recreational, and industrial applications. The Engineered Products segment fabricates finished aircraft structures and components such as wing-to-body fairings, flight deck panels, rotorcraft blades, and engine nacelle parts, along with RF interference control products for military and aerospace use.
The company serves the commercial aerospace, defense and space, and industrial end markets, selling directly through internal sales personnel and via independent distributors across the Americas, Europe, Asia Pacific, India, and Africa. Hexcel is classified in the GICS Industrials sector, specifically the Aerospace & Defense sub-industry, and is a key supplier of carbon fiber and advanced composite structures used by aircraft manufacturers to reduce airframe weight and improve fuel efficiency. Founded in 1946 and headquartered in Stamford, Connecticut, Hexcel has been publicly traded since its 1987 IPO.
- Boeing and Airbus production rate hikes lift composite materials volumes
- Defense and space backlog expands with rotorcraft and F-35 demand
- European wind energy demand softens amid project delays and pricing pressure
| Net Income: 171.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 1.03 > 1.0 |
| NWC/Revenue: 24.22% < 20% (prev 26.72%; Δ -2.50% < -1%) |
| CFO/TA 0.11 > 3% & CFO 296.6m > Net Income 171.5m |
| Net Debt (859.2m) to EBITDA (368.1m): 2.33 < 3 |
| Current Ratio: 2.57 > 1.5 & < 3 |
| Outstanding Shares: last quarter (76.7m) vs 12m ago -4.48% < -2% |
| Gross Margin: 24.78% > 18% (prev 23.04%; Δ 1.74% > 0.5%) |
| Asset Turnover: 73.31% > 50% (prev 68.02%; Δ 5.29% > 0%) |
| Interest Coverage Ratio: 5.20 > 6 (EBIT TTM 246.8m / Interest Expense TTM 47.5m) |
| A: 0.18 (Total Current Assets 798.0m - Total Current Liabilities 310.7m) / Total Assets 2.73b |
| B: 0.88 (Retained Earnings 2.39b / Total Assets 2.73b) |
| C: 0.09 (EBIT TTM 246.8m / Avg Total Assets 2.74b) |
| D: 0.94 (Book Value of Equity 1.32b / Total Liabilities 1.40b) |
| Altman-Z'' = 5.62 = AAA |
| DSRI: 0.93 (Receivables 271.6m/273.2m, Revenue 2.01b/1.88b) |
| GMI: 0.93 (GM 23.04% / 24.78%) |
| AQI: 1.00 (AQ_t 0.13 / AQ_t-1 0.13) |
| SGI: 1.07 (Revenue 2.01b / 1.88b) |
| TATA: -0.05 (NI 171.5m - CFO 296.6m) / TA 2.73b) |
| Beneish M = -3.10 (Cap -4..+1) = AA |
As of November 13, 2026, the stock is trading at USD 79.91 with a total of 996,559 shares traded. Over the past week, the price has changed by -0.88%, over one month by -5.71%, over three months by -21.71% and over the past year by +17.21%.
Current recommended Stop Loss: 75.00 (which is 6.1% or 1.7 ATR below the current price).
Hexcel has received a consensus analysts rating of 3.71. Therefore, it is recommended to hold HXL.
- StrongBuy: 5
- Buy: 2
- Hold: 10
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 98.9 | 23.7% |
P/E Trailing = 36.2162
P/E Forward = 21.0526
P/S = 3.0153
P/B = 4.5956
P/EG = 0.6367
Revenue TTM = 2.01b USD
EBIT TTM = 246.8m USD
EBITDA TTM = 368.1m USD
Long Term Debt = 932.8m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 937.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 2.10m
Net Debt = 859.2m USD (calculated: Debt 937.0m - CCE 77.8m)
Enterprise Value = 6.95b USD (6.09b + Debt 937.0m - CCE 77.8m)
Interest Coverage Ratio = 5.20 (Ebit TTM 246.8m / Interest Expense TTM 47.5m)
EV/FCF = 31.57x (Enterprise Value 6.95b / FCF TTM 220.0m)
FCF Yield = 3.17% (FCF TTM 220.0m / Enterprise Value 6.95b)
FCF Margin = 10.94% (FCF TTM 220.0m / Revenue TTM 2.01b)
Net Margin = 8.53% (Net Income TTM 171.5m / Revenue TTM 2.01b)
Gross Margin = 24.78% ((Revenue TTM 2.01b - Cost of Revenue TTM 1.51b) / Revenue TTM)
Gross Margin QoQ = 23.27% (prev 26.09%)
Tobins Q-Ratio = 2.54 (Enterprise Value 6.95b / Total Assets 2.73b)
Interest Expense / Debt = 5.07% (Interest Expense 47.5m / Debt 937.0m)
Taxrate = 13.95% (27.8m / 199.3m)
NOPAT = 212.4m (EBIT 246.8m * (1 - 13.95%))
Current Ratio = 2.57 (Total Current Assets 798.0m / Total Current Liabilities 310.7m)
Debt / Equity = 0.71 (Debt 937.0m / totalStockholderEquity, last quarter 1.32b)
Debt / EBITDA = 2.33 (Net Debt 859.2m / EBITDA 368.1m)
Debt / FCF = 3.91 (Net Debt 859.2m / FCF TTM 220.0m)
Total Stockholder Equity = 1.28b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.25% (Net Income 171.5m / Total Assets 2.73b)
RoE = 13.35% (Net Income TTM 171.5m / Total Stockholder Equity 1.28b)
RoCE = 11.13% (EBIT 246.8m / Capital Employed (Equity 1.28b + L.T.Debt 932.8m))
RoIC = 9.07% (NOPAT 212.4m / Invested Capital 2.34b)
WACC = 8.46% (E(6.09b)/V(7.02b) * Re(9.09%) + D(937.0m)/V(7.02b) * Rd(5.07%) * (1-Tc(0.14)))
Discount Rate = 9.09% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.34 | Cagr: -3.55%
[DCF] Terminal Value 77.37% ; FCFF base≈209.6m ; Y1≈237.1m ; Y5≈337.4m
[DCF] Fair Price = 54.66 (EV 5.00b - Net Debt 859.2m = Equity 4.14b / Shares 75.7m; r=8.46% [WACC]; 5y FCF grow 13.46% → 2.50% )
EPS Correlation: 58.56 | EPS CAGR: 5.47% | SUE: 0.31 | # QB: 0
Revenue Correlation: 90.47 | Revenue CAGR: 3.37% | SUE: -0.58 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.66 | Chg30d=+0.12% | Revisions=-22% | Analysts=9
EPS current Year (2026-12-31): EPS=2.38 | Chg30d=-0.65% | Revisions=+0% | GrowthEPS=+35.4% | GrowthRev=+9.7%
EPS next Year (2027-12-31): EPS=3.11 | Chg30d=-0.85% | Revisions=-53% | GrowthEPS=+30.6% | GrowthRev=+11.1%
[Analyst] Revisions Ratio: -30% (up=10, down=20)